Anti-KRAS
- Primary DI
- 00810119672421
- Brand
- Anti-KRAS
- Company
- BIOGENEX LABORATORIES
- Model
- AR751-5R
- Catalog number
- AR751-5R
- Published
- 2026-09-18
- Public version status
- New
- Distribution status
- In Commercial Distribution
- MRI safety
- Labeling does not contain MRI Safety Information
- Rx
- false
- OTC
- true
- Sterile
- false
- Single use
- false
Product Codes#
| Code | Name |
|---|---|
| NJT | Immunohistochemistry Reagents And Kits |
Product Code Classifications#
| Code | Device | Specialty | Class |
|---|---|---|---|
| NJT | Immunohistochemistry Reagents And Kits | Hematology | 1 |
Identifiers And Packaging#
| Identifier | Type | Agency | Package quantity | Status |
|---|---|---|---|---|
| 00810119672421 | Primary | GS1 | 0 |
Alternate GTIN / UPC / EAN Codes
| Source identifier | GTIN-14 normalized | UPC-A | EAN-13 |
|---|---|---|---|
| 00810119672421 | 00810119672421 | 810119672421 | 0810119672421 |
GMDN Terms#
| Term | Definition |
|---|---|
| KRAS gene mutation IVD, kit, nucleic acid technique (NAT) | A collection of reagents and other associated materials intended to be used for the qualitative detection of the KRAS (v-ki-ras2 kirsten rat sarcoma viral oncogene homolog) mutation status and/or to evaluate a clinical specimen to predict or monitor the response to treatment with epidermal growth factor receptor (EGFR) inhibitors by determining the KRAS mutation status of tumour tissue using a nucleic acid technique (NAT). |
Regulatory Flags#
- DUNS number
- 042697045
- Device count
- 1
- DM exempt
- false
- Premarket exempt
- true
- HCT/P
- false
- Kit
- false
- Combination product
- false
- Lot or batch
- true
- Serial number
- false
- Manufacturing date on label
- false
- Expiration date on label
- true
- Donation ID number
- false
- Contains natural rubber latex
- false
- No natural rubber latex
- false
- Sterilization required before use
- false
Other Devices From This Company#
| Primary DI | Brand | Model | Catalog | Published |
|---|---|---|---|---|
| 00840542207594 | Anti-CD2 | AM438-10M | AM438-10M | 2026-09-18 |
| 00840542207600 | Anti-CD2 | AX438-50D | AX438-50D | 2026-09-18 |
| 00840542207693 | Anti-Inhibin-Alpha | AM446-10M | AM446-10M | 2026-09-18 |
| 00840542207709 | Anti-Inhibin-Alpha | AX446-50D | AX446-50D | 2026-09-18 |
| 00840542207716 | Anti-Inhibin-Alpha | AX446-YCD | AX446-YCD | 2026-09-18 |
| 00840542210181 | Anti-CD90 | AN733-5M | AN733-5M | 2026-09-18 |
| 00840542210198 | Anti-CD90 | AN733-10M | AN733-10M | 2026-09-18 |
| 00840542210204 | Anti-CD90 | AY733-50D | AY733-50D | 2026-09-18 |
| 00840542210211 | Anti-CD90 | AY733-YCD | AY733-YCD | 2026-09-18 |
| 00840542210228 | Anti-CD90 | NU733-UC | NU733-UC | 2026-09-18 |
| 00840542210235 | Anti-CD90 | NU733-5UC | NU733-5UC | 2026-09-18 |
| 00840542210242 | Anti-CD53 | AN734-5M | AN734-5M | 2026-09-18 |
| 00840542210259 | Anti-CD53 | AN734-10M | AN734-10M | 2026-09-18 |
| 00840542210266 | Anti-CD53 | AY734-50D | AY734-50D | 2026-09-18 |
| 00840542210372 | Anti-CD205 | AN737-10ME | AN737-10ME | 2026-09-18 |
| 00840542210389 | Anti-CD205 | AY737-50DE | AY737-50DE | 2026-09-18 |
| 00840542210396 | Anti-CD205 | AY737-YCDE | AY737-YCDE | 2026-09-18 |
| 00840542210402 | Anti-CD205 | NU737-UCE | NU737-UCE | 2026-09-18 |
| 00840542210419 | Anti-CD205 | NU737-5UCE | NU737-5UCE | 2026-09-18 |
| 00840542210426 | Anti-CD103 | AN739-5ME | AN739-5ME | 2026-09-18 |
Other Devices Sharing Product Codes#
| Primary DI | Brand | Company | Product code | Published |
|---|---|---|---|---|
| 00840542207594 | Anti-CD2 | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542207600 | Anti-CD2 | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542207693 | Anti-Inhibin-Alpha | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542207709 | Anti-Inhibin-Alpha | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542207716 | Anti-Inhibin-Alpha | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542210181 | Anti-CD90 | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542210198 | Anti-CD90 | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542210204 | Anti-CD90 | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542210211 | Anti-CD90 | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542210228 | Anti-CD90 | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542210235 | Anti-CD90 | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542210242 | Anti-CD53 | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542210259 | Anti-CD53 | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542210266 | Anti-CD53 | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542210426 | Anti-CD103 | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542210433 | Anti-CD103 | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542210457 | Anti-CD103 | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542210464 | Anti-CD103 | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542210945 | ANTI-KRAS | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542210952 | ANTI-KRAS | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542211201 | Anti-CD82 | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542211218 | Anti-CD82 | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00840542223280 | Anti-Inhibin Alpha | BIOGENEX LABORATORIES | NJT | 2026-09-18 |
| 00841683151340 | Arginase-1 SP156 Rab. | CELL MARQUE CORPORATION | NJT | 2026-09-04 |
| 00841683151364 | CD163 MRQ-26 Mab. | CELL MARQUE CORPORATION | NJT | 2026-09-04 |
| 00841683151371 | Cytokeratin 5 & 6 D5 & 16B4 Mab. | CELL MARQUE CORPORATION | NJT | 2026-09-04 |
| 00841683151388 | Ep-CAM MOC31 Mab. | CELL MARQUE CORPORATION | NJT | 2026-09-04 |
| 00841683151395 | GATA3 L50-823 Mab. | CELL MARQUE CORPORATION | NJT | 2026-09-04 |
| 00841683151401 | Glypican-3 1G12 Mab. | CELL MARQUE CORPORATION | NJT | 2026-09-04 |
| 00841683151418 | Hepatocyte Specific Antigen (Hep-Par 1) OCH1E5 Mab. | CELL MARQUE CORPORATION | NJT | 2026-09-04 |